Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Expect ZERO clarity from the management about anything that a business analyst would want to know about a company in order to make reasoned predictions about present/future valuation. The are unwilling (or unable) to communicate this sort of information—at least over the course of the 3 years that I’ve seen. Is it any wonder, then, that we’ve seen what we have with the OS, the PPS, and LAUGHABLE revenues from a company that has been in the “commercialization” stage with its first line, CaverStem, for over two years (reaching back FAR before the pandemic)?